SB INVESTMENT ADVISERS (UK) LTD
Long book
$7.73B
Q1 2026
Positions
10
Top-10 weight
100%
concentration
Last quarter
+6.0%
SPY +14.8%
Turnover
0%
of book per quarter
Strategy in plain words
auto-generated from filingsSB INVESTMENT ADVISERS (UK) LTD is a concentrated fundamental stock-picker, specialised in consumer_discretionary (71% of the long book), running a $7.73B US long book across 10 positions.
The portfolio is extremely concentrated — the top 10 positions are almost the whole book. The book barely moves quarter to quarter — a patient, low-turnover holder. Current anchor positions: COUPANG INC, GRAB HOLDINGS LTD - CL A, RELAY THERAPEUTICS INC, COMPASS INC - CLASS A, VIR BIOTECHNOLOGY INC.
Over the last 9 quarters its long book ran on average 1.1pp per quarter behind the S&P 500, beating the index in 5 of 9 quarters. We rate its filings highest-signal: new buys here are worth attention.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q1 2024
+9.9%
Q2 2024
+17.5%
Q3 2024
-4.3%
Q4 2024
-0.5%
Q1 2025
+26.7%
Q2 2025
+12.0%
Q3 2025
-18.6%
Q4 2025
-18.4%
Q1 2026
+6.0%
Sector allocation
Consumer discretionary 71%
Services media 19%
Healthcare 6%
Real estate 2%
Technology 2%
Long book by quarter
What does SB INVESTMENT own?
Q1 2026 13F| Company | Sector | Shares | Value | % of book | Change |
|---|---|---|---|---|---|
| CPNG COUPANG INC | Consumer discretionary | 289.5M | $5.47B | 70.7% | Held |
| GRAB GRAB HOLDINGS LTD - CL A | Services media | 401.8M | $1.47B | 19.0% | Held |
| RLAY RELAY THERAPEUTICS INC | Healthcare | 27.9M | $277.7M | 3.6% | Held |
| COMP COMPASS INC - CLASS A | Real estate | 22.0M | $160.9M | 2.1% | -12.2% |
| VIR VIR BIOTECHNOLOGY INC | Healthcare | 10.9M | $98.1M | 1.3% | -16.5% |
| AUR AURORA INNOVATION INC | Technology | 19.8M | $81.6M | 1.1% | Held |
| ROIV ROIVANT SCIENCES LTD | Healthcare | 2.7M | $74.0M | 1.0% | -83.7% |
| NRGV ENERGY VAULT HOLDINGS INC | Technology | 15.5M | $51.3M | 0.7% | -16.2% |
| DNA GINKGO BIOWORKS HOLDINGS INC | Healthcare | 610.7K | $3.7M | 0.0% | Held |
13F filing history
| Period | Form | Filed | Entries | Reported value | Flags | Source |
|---|---|---|---|---|---|---|
| Q1 2026 | 13F-HR | May 18, 2026 | 10 | $7.73B | canonical | SEC ↗ |
| Q4 2025 | 13F-HR | Feb 18, 2026 | 10 | $9.99B | canonical | SEC ↗ |
| Q3 2025 | 13F-HR | Nov 14, 2025 | 10 | $13.25B | canonical | SEC ↗ |
| Q2 2025 | 13F-HR/ARESTATEMENT | Nov 14, 2025 | 10 | $12.61B | canonical | SEC ↗ |
| Q2 2025 | 13F-HR | Aug 14, 2025 | 10 | $12.61B | SEC ↗ | |
| Q1 2025 | 13F-HR | May 15, 2025 | 10 | $10.97B | canonical | SEC ↗ |
| Q4 2024 | 13F-HR | Feb 14, 2025 | 10 | $11.38B | canonical | SEC ↗ |
| Q3 2024 | 13F-HR | Nov 14, 2024 | 11 | $12.14B | canonical | SEC ↗ |
| Q2 2024 | 13F-HR | Aug 14, 2024 | 12 | $10.82B | canonical | SEC ↗ |
| Q1 2024 | 13F-HR | May 15, 2024 | 13 | $10.13B | canonical | SEC ↗ |